MDCP | VO | MDCP / VO | |
Gain YTD | 3.612 | 3.669 | 98% |
Net Assets | 82.5M | 177B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 20.00 | 13.00 | 154% |
Yield | 0.36 | 1.50 | 24% |
Fund Existence | 3 years | 21 years | - |
MDCP | VO | |
---|---|---|
RSI ODDS (%) | 11 days ago88% | 11 days ago84% |
Stochastic ODDS (%) | N/A | 11 days ago90% |
Momentum ODDS (%) | N/A | 11 days ago80% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 11 days ago68% | 11 days ago85% |
TrendMonth ODDS (%) | 11 days ago72% | 11 days ago79% |
Advances ODDS (%) | N/A | 13 days ago84% |
Declines ODDS (%) | 12 days ago67% | 17 days ago79% |
BollingerBands ODDS (%) | 11 days ago77% | N/A |
Aroon ODDS (%) | 11 days ago80% | 11 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DVOL | 35.11 | 0.16 | +0.45% |
FirstTrustDorseyWrightMomt&LwVolatil ETF | |||
XMMO | 129.69 | 0.58 | +0.45% |
Invesco S&P MidCap Momentum ETF | |||
TPSC | 40.22 | 0.16 | +0.39% |
Timothy Plan US Small Cap Core ETF | |||
LGOV | 20.81 | 0.04 | +0.19% |
First Trust Long Duration Opp ETF | |||
CNCR | 11.67 | -0.03 | -0.26% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, MDCP has been closely correlated with GGG. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MDCP jumps, then GGG could also see price increases.
Ticker / NAME | Correlation To MDCP | 1D Price Change % | ||
---|---|---|---|---|
MDCP | 100% | +0.29% | ||
GGG - MDCP | 74% Closely correlated | +0.47% | ||
NVR - MDCP | 73% Closely correlated | +0.08% | ||
LFUS - MDCP | 72% Closely correlated | +0.88% | ||
POOL - MDCP | 70% Closely correlated | +0.21% | ||
GXO - MDCP | 70% Closely correlated | -0.95% | ||
More |